Meningococcal ACWY Vaccine (Travel)

A quadrivalent conjugate vaccine against meningococcal serogroups A, C, W, and Y. Mandatory for pilgrims travelling to Saudi Arabia for Hajj or Umrah; recommended for travel to the 'Meningitis Belt' of sub-Saharan Africa.

The Meningococcal ACWY Vaccine (Travel) is recommended for 2 years and above; required ≥10 days before Hajj/Umrah entry. It falls under the Travel vaccine category. Consult your doctor to confirm if this vaccine is right for you based on your health history and existing immunity.

The Meningococcal ACWY Vaccine (Travel) has an efficacy of 85–100%. This means it provides significant protection against Meningococcal Meningitis (A and C. Efficacy may vary based on age, health status, and the specific strain encountered.

Common side effects include: Injection site pain; redness; mild fever; headache. These are typically mild and resolve within 1–3 days. Serious allergic reactions are rare — if you experience difficulty breathing, hives, or rapid heartbeat after vaccination, seek emergency care immediately.

The Meningococcal ACWY Vaccine (Travel) should be avoided by: Severe allergy to a previous meningococcal vaccine dose. Always inform your healthcare provider of your full medical history before vaccination.

The Meningococcal ACWY Vaccine (Travel) typically costs ₹1,500 – ₹3,500 in India. Government health centres may offer it free or at subsidised prices for eligible age groups. Private hospitals and clinics may charge differently. Additional fees may apply for administration.